Trademark: 90818799
Word
COVERMYMEDS
Status
Pending
Status Code
688
Status Date
Tuesday, December 12, 2023
Serial Number
90818799
Mark Type
4000
Filing Date
Thursday, July 8, 2021
Published for Opposition
Tuesday, October 17, 2023

Trademark Owner History
CoverMyMeds LLC - Owner At Publication

Classifications
38 Electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments, and referrals that allow direct transaction and payment communications between healthcare providers, pharmacies, and payers
36 Financial administration of pharmaceutical manufacturer program that redeploys rebate funds directly to underinsured or uninsured consumers at the pharmacy counter; providing a patient financial assistance and financial support program for patients and their healthcare providers for the purpose of facilitating good health, namely, providing financial information about medication, access to medical care, medication insurance coverage, benefits verification, reimbursement, payer policies and patient financial assistance
45 Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication
44 Providing medical advice and information about medication, access to medical care, medication insurance coverage, benefits verification, reimbursement, payer policies and patient financial assistance; medication counseling, namely providing information about taking medication, medication side-effects, allergic sensitivity to medications, drug interactions, medication tolerance, and alternate medication brands and generics
42 Providing temporary use of a web-based software application for use in providing support for pharmacies and health systems that integrates with pharmacy management systems to facilitate dispensing of pharmaceuticals via remote prescription verification, audit trails with images of dispensed drug, alerts to avoid duplicate patient therapy, allergies, and drug interactions; Software as a service (SAAS) services featuring software for facilitating the prescription of, and access to covered specialty medications and medical treatments by enabling intra provider-insurer-pharmacy communications for purposes of investigating and verifying patient-specific benefits coverage, for processing prior medical authorizations, for locating and facilitating patient access to financial assistance, for scheduling laboratory tests and first dose observations, for transmitting prescriptions to a patient's preferred pharmacy, and for supporting pharmaceutical companies in risk evaluation and mitigation strategy programs, and, as related to the above, specifically excluding software permitting health care providers and patients to communicate via a customized private website to collect, analyze, manage, share, report or compare patient data, rehabilitation tracking and patient progress; Software as a service featuring software for integration of medical software with drug interaction references and recommendations from medical databases; Software as a service (SAAS) namely, hosting an online software platform for use by others that provides online price comparisons, cost analysis, coupons, and price quotations of pharmaceuticals and over the counter medications for consumers, providers, administrators, and other participants in the healthcare industry; Software as a service (SAAS) services featuring software for use by medical care providers, pharmacists, and benefit providers for utilizing, aggregating, analyzing, displaying, and updating medical health record data analytics, for use in prior authorization support, prescription benefit support, prescription decision support, and medical care support to improve clinical outcomes; Software as a service (SAAS) services featuring software for the purpose of integrating medical information in the fields of pharmaceuticals, drug interactions, and treatment guidelines for the purpose of reducing the time and effort required from all stakeholders to start specialty therapy with the goal of improving patient outcomes
COVER MY MEDICATION

Trademark Events
Dec 12, 2023
Noa E-Mailed - Sou Required From Applicant
Oct 17, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 17, 2023
Published For Opposition
Sep 27, 2023
Notification Of Notice Of Publication E-Mailed
Sep 10, 2023
Approved For Pub - Principal Register
Sep 9, 2023
Teas/Email Correspondence Entered
Sep 8, 2023
Correspondence Received In Law Office
Sep 8, 2023
Teas Request For Reconsideration Received
Jun 8, 2023
Notification Of Final Refusal Emailed
Jun 8, 2023
Final Refusal E-Mailed
Jun 8, 2023
Final Refusal Written
May 8, 2023
Teas/Email Correspondence Entered
May 8, 2023
Correspondence Received In Law Office
May 8, 2023
Teas Response To Office Action Received
Nov 7, 2022
Notification Of Non-Final Action E-Mailed
Nov 7, 2022
Non-Final Action E-Mailed
Nov 7, 2022
Non-Final Action Written
Oct 1, 2022
Teas/Email Correspondence Entered
Sep 30, 2022
Correspondence Received In Law Office
Sep 30, 2022
Teas Response To Office Action Received
Mar 30, 2022
Notification Of Non-Final Action E-Mailed
Mar 30, 2022
Non-Final Action E-Mailed
Mar 30, 2022
Non-Final Action Written
Mar 27, 2022
Assigned To Examiner
Sep 16, 2021
New Application Office Supplied Data Entered
Jul 12, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24